Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | HRH1 | P35367 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.50 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10768152 | 1.00 | MEN1 (0.59) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL27735835 | 0.84 | LMNA (0.56) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL1359383 | 0.83 | MEN1 (0.49) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Creatine SCHEMBL5422996 | 0.81 | MEN1 (0.41) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Creatine SCHEMBL5422993 | 0.81 | MEN1 (0.41) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL4256715 | 0.81 | MEN1 (0.71) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL17629809 | 0.81 | MEN1 (0.71) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL1208087 | 0.81 | MEN1 (0.71) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL10904306 | 0.79 | MEN1 (0.87) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Acetylcarnitine SCHEMBL10904308 | 0.79 | MEN1 (0.87) | MEN1KMT2ACYP1A2HRH1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346735-A1 | Nutritional Composition Comprising Carnitine and Method for Treating or Preventing an Infection in a Mammal | LONZA GREENWOOD LLC | 2023-11-02 | — | — | US | claimed |
| EP-4125858-A1 | NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL | Lonza Consumer Health Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| WO-2021221741-A1 | NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL | LONZA CONSUMER HEALTH INC. (US) | 2021-11-04 | — | — | WO | claimed |
| US-4602039-A | HYDROPHOPIC;BIOLOGICAL INJECTIONS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1986-07-22 | — | — | US | claimed |
| JP-63267716-A | — | — | None | — | — | JP | disclosed |
| EP-4125858-B1 | NUTRITIONAL COMPOSITION COMPRISING L-CARNITINE TARTRATE FOR USE IN TREATING OR PREVENTING A CORONAVIRUS INFECTION IN A MAMMAL | LONZA GREENWOOD LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| CN-119894823-A | Stable silicic acid solutions | 巴尔拉有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20240424007-A1 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES | Jazz Pharmaceuticals Therapeutics, Inc. | 2024-12-26 | — | — | US | disclosed |
| US-12070471-B2 | Remote loading of sparingly water-soluble drugs into lipid vesicles | CELATOR PHARMACEUTICALS, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| CN-118159260-A | Compositions and methods for preventing or reducing the risk of metabolic syndrome | 费尔南多·加西亚·萨达 | 2024-06-07 | — | — | CN | disclosed |
| EP-4309657-A2 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES | Celator Pharmaceuticals, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20230390317-A1 | Remote Loading of Sparingly Water-Soluble Drugs Into Lipid Vesicles | Jazz Pharmaceuticals Therapeutics, Inc. | 2023-12-07 | — | — | US | disclosed |
| WO-2014121211-A2 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES | ZONEONE PHARMA, INC. (US) | 2014-08-07 | — | — | WO | disclosed |
| WO-2012035364-A1 | STABILIZED SOLUTION OF ORTHO-SILICIC ACID, ITS PREPARATION AND USE | CREOGEN D.O.O. (HR) | 2012-03-22 | — | — | WO | disclosed |
| EP-0348859-A1 | 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them | MAGIS FARMACEUTICI S.p.A. (IT) | 1990-01-03 | — | — | EP | disclosed |
| EP-0348859-A1 | 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them | MAGIS FARMACEUTICI S.p.A. (IT) | 1990-01-03 | — | — | EP | disclosed |
| JP-S63267716-A | REMEDY FOR UREA CYCLE DYSBOLISM | EARTH CHEM CORP LTD | 1988-11-04 | — | — | JP | disclosed |
| EP-0150688-B1 | SALTS OF L-CARNITINE AND ALKANOYL L-CARNITINES AND PROCESS FOR PREPARING SAME | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1987-04-22 | — | — | EP | disclosed |
| US-4602039-A | HYDROPHOPIC;BIOLOGICAL INJECTIONS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1986-07-22 | — | — | US | disclosed |
| EP-0150688-A1 | Salts of L-carnitine and alkanoyl L-carnitines and process for preparing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1985-08-07 | — | — | EP | disclosed |